Last reviewed · How we verify

NCT03759574

Pathophysiologic Hemodynamics After Primary Unilateral Total Hip Arthroplasty (THA)

Status unknown Last updated 28 January 2020
What this trial tests

trial in Orthostatic Intolerance in 26 participants. Status unknown.

Timeline
18 March 2019
Primary endpoint
1 January 2021
15 May 2021

Quick facts

Lead sponsorHvidovre University Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment26
Start date18 March 2019
Primary completion1 January 2021
Estimated completion15 May 2021
Sites1 location across Denmark

Conditions studied

Sponsor

Hvidovre University Hospital

Who can join

Adults 18 to 65, any sex, with Orthostatic Intolerance or Orthostatic Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Incidence and pathophysiologic hemodynamics of orthostatic intolerance and orthostatic hypotension in patients undergoing unilateral THA

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Orthostatic Intolerance

Currently open trials in the same condition.

Other Hvidovre University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03759574.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing